Givinostat 50 mg capsules, RIVAROXABAN , ACETYLSALICYLIC ACID , Givinostat 100 mg capsules, HYDROXYCARBAMIDE, ENOXAPARIN , -, Givinostat 75 mg capsules, DABIGATRAN ETEXILATE
DSC/08/2357/32
Phase 3 small_molecule active
Quick answer
Givinostat 50 mg capsules, RIVAROXABAN , ACETYLSALICYLIC ACID , Givinostat 100 mg capsules, HYDROXYCARBAMIDE, ENOXAPARIN , -, Givinostat 75 mg capsules, DABIGATRAN ETEXILATE for JAK2V617F-positive high-risk Polycythemia Vera is a Phase 3 program (small_molecule) at Italfarmaco S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Italfarmaco S.p.A.
- Indication
- JAK2V617F-positive high-risk Polycythemia Vera
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active